Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
about
Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activationPotential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cellsMEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel diseaseCytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosisMicroRNAs: Novel immunotherapeutic targets in colorectal carcinomaSTAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancerOverview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseasesThe relationship between the immune system and oral manifestations of inflammatory bowel disease: a reviewCancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effectsIL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancerThe macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages.Diminished macrophage apoptosis and reactive oxygen species generation after phorbol ester stimulation in Crohn's disease.C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot studyClone-specific expression, transcriptional regulation, and action of interleukin-6 in human colon carcinoma cellsA novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesisInvolvement of NF-κB/IL-6 Pathway in the Processing of Colorectal Carcinogenesis in Colitis MiceDeletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitisComorbidity of Allergic and Autoimmune Diseases Among Patients With ADHD.Animal models of colitis-associated carcinogenesis.Balance of meprin A and B in mice affects the progression of experimental inflammatory bowel disease.MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.Network modelling reveals the mechanism underlying colitis-associated colon cancer and identifies novel combinatorial anti-cancer targets.Inflammatory bowel "Cardiac" disease: Point prevalence of atrial fibrillation in inflammatory bowel disease population.Effects of growth arrest and DNA damage-inducible protein 34 (GADD34) on inflammation-induced colon cancer in miceCytokines, inflammation and colon cancerInterleukin-6 is linked to longitudinal rates of cortical thinning in agingThe Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis.STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease.Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress.Expression of the novel adipokine C1qTNF-related protein 4 (CTRP4) suppresses colitis and colitis-associated colorectal cancer in mice.Flavonoids Extracted from Licorice Prevents Colitis-Associated Carcinogenesis in AOM/DSS Mouse Model.Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formationDeoxyschizandrin suppresses dss-induced ulcerative colitis in mice.Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases.Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6.Meprin metalloproteases inactivate interleukin 6.SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development.
P2860
Q24656274-B3798431-07CF-48D8-836E-8B2EDAB72DA9Q24656942-FAA3C9EA-A753-4669-B3C8-76807E7C2759Q24657607-ECF19AA3-00B1-4227-A945-6B4D9277C60AQ26741263-B5028927-C733-4CCD-B616-2E1881739559Q26747339-3B71B45D-E24A-44B7-85EE-74512F005B9CQ26998940-4CD9BBF8-35F3-41A5-8F08-62154FDB84F2Q28069372-56D513B4-96BE-45CF-905D-320B18A409FBQ28078219-4263641C-7C13-46F3-BFFD-E4C75B3822F5Q28307374-15E5F68F-22BC-40BA-B205-817D53AD19ECQ29614594-FB0113D0-DD4E-4D4D-AC18-EA0434C2118AQ30407722-BE6B1630-BDAB-4539-AE19-D7822FADC4F6Q30882939-920B626C-3B53-4C86-8F11-8C0696363AC0Q33275999-F7C6D1F9-DBE8-4AFA-9DF8-6F6403C56AE7Q33315459-88C88F4D-F8BC-4E26-A6E6-2F184F81B882Q33597235-963F47D3-A145-4030-B82F-5D4C82F8F368Q33908674-5AA57EF2-531C-4C31-8A40-99C9A9AC0CB6Q34116480-8AB594BA-51C3-40C6-8EB9-CDF16A27918BQ34327276-898EB313-42B6-4435-B886-B3D204C62280Q34512820-D28AF53A-6484-4243-88AB-4F408465476AQ34597685-D4B0125A-01A5-4649-A776-E706147BED99Q34821676-CD8707FA-E879-4F75-86D6-17A8EA017995Q35010521-510C72CC-B719-4C20-9CF7-D319CE8E0111Q35012014-D65A3A07-B910-4E18-8361-BBADEF7B4624Q36134211-7F6A16ED-B7EF-42B5-828F-BEA2C56C11E6Q36246335-9580F140-11B8-4F0C-AA5B-E49DE09B27C8Q36287084-AB368FEE-1115-48AA-A5AD-DE79DFC77EBBQ36520856-51976B44-9A27-45ED-ABB2-4106AA7E12B4Q36778655-0017BB3A-5641-41E3-8DC3-73C6C14FAA8FQ36860902-589478A0-2691-457E-8611-B22CF36B1C80Q36986500-9876D488-7173-423B-A455-0449EF36F24BQ37003577-8F5CBF5D-A98E-40A1-AB0D-C7A5147599D1Q37063499-9CEC4630-CA93-4D4C-B260-FFB5BA5D9DC8Q37285021-159408C8-B9AF-4762-9CE6-3A0051B6E363Q37286193-CE1C67DF-78FC-462A-BB28-0BDB825C4616Q37292706-000DAE62-1CE0-4968-9351-4462CC9D6CD7Q37532253-56936993-7493-4ADE-951D-645259E78B92Q37537109-BFA7E713-75A6-4C00-B802-347A8A8674B0Q37625690-B71EE110-520B-42FC-884E-AE5ED13DADCEQ37635798-C52C9B14-4498-4CB1-BA48-C940FB85F0B4Q37662297-421CD7F7-12BA-442F-A077-11EA45F6BF2B
P2860
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
@ast
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
@en
type
label
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
@ast
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
@en
prefLabel
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
@ast
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
@en
P356
P1476
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
@en
P2093
Markus F Neurath
Raja Atreya
P2888
P304
P356
10.1385/CRIAI:28:3:187
P577
2005-06-01T00:00:00Z
P6179
1025022759